← All diseases

Lysosomal storage diseases

Acid sphingomyelinase deficiency (ASMD, Niemann-Pick disease types A/B)

An inherited disease caused by a fat building up in the cells. The liver, spleen and lungs are affected. In the severe type, the brain is also affected.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

This page is translated from the Turkish original.

This disease is followed through the “Lysosomal storage diseases” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

An enzyme called acid sphingomyelinase is missing in the cells. Because of this, a fat called sphingomyelin cannot be broken down and builds up in the cells. The liver, spleen, lungs and bone marrow are affected. In the severe type, the brain is also affected.

Which symptoms can occur?

The disease has a severe infantile type (type A) and a milder type (type B). Types in between are also seen. Symptoms vary greatly from person to person.

  • Enlarged liver and spleen (common)
  • Poor weight gain and slow growth
  • Frequent lung infections and shortness of breath
  • Low platelets in the blood, easy bruising and bleeding
  • Abnormal blood fat levels (in type B)
  • Thinning of the bones
  • Loss of developmental skills (in type A)

How is it diagnosed?

The doctor examines the person and checks the size of the liver and spleen. The activity of the enzyme acid sphingomyelinase is measured in the blood. The diagnosis is confirmed with a genetic test that looks at the SMPD1 gene.

Treatment and care

There is an approved enzyme treatment specific to the disease. This treatment reduces the build-up in the liver, spleen and lungs. However, it does not act on the effects in the brain. Nutritional support, breathing support, physiotherapy and regular follow-up are also part of care. People with a large spleen should avoid contact sports. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

The disease is passed on through recessive inheritance. The mother and father are usually healthy carriers. For a couple who are both carriers, the chance of having an affected child is 1 in 4 in each pregnancy. Diseases of this kind may be more common in marriages between relatives. Carrier testing and testing during pregnancy are possible. Genetic counselling is recommended.

Source: MedlinePlus Genetics: Niemann-Pick disease · GeneReviews: Acid Sphingomyelinase Deficiency · NORD: Acid Sphingomyelinase Deficiency

Key facts

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

For all rare diseases: Nadir Hastalıklar Federasyonu

Links checked on October 8, 2026.

Guides related to this disease

  • Home care and medical devices · Home health service, oxygen and respiratory device reports, wheelchairs and orthoses, power outage notification, emergency plan.

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about Niemann-Pick A/B

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.

See all studies on ClinicalTrials.gov · Joining clinical trials

Lysosomal storage diseases: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:618899

No matching ICD-11 entry was found.

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.